Fingerprint
Dive into the research topics where François Kavelaars is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities
Boertjes, E. L., Grob, T., Al Hinai, A., Beverloo, B. H. B., Versluis, J., Kavelaars, F. G., Rijken, M., Compagne, K. G., Erpelinck, C. A. J., Sanders, M. A., Stoetman, E. C. G., Hanekamp, D., Gradowska, P. L., Ossenkoppele, G. J., Biemond, B. J., Manz, M. G., Pabst, T., Jongen-Lavrencic, M., Löwenberg, B. & Valk, P. J. M., 24 Feb 2026, In: Blood Advances. 10, 4, p. 939-950 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile32 Downloads (Pure) -
Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia
Boertjes, E. L., Vonk, C. M., Kavelaars, F. G., Engvall, M., Nordin, S., Beugelink, L., Rijken, M., Konijnenburg, J. M. L., Versluis, J., Löwenberg, B. & Valk, P. J. M., 14 Oct 2025, In: Blood Advances. 9, 19, p. 4860-4869 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Scopus)29 Downloads (Pure) -
Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B-ALL, or T-ALL
Mulet-Lazaro, R., Sijs-Szabó, A., Hoogenboezem, R. M., van Herk, S., Exalto, C., Koenders, J. E., Hoogeveen, P. G., Kavelaars, F. G., Schelen, A. M., van den Ancker, W., van de Loosdrecht, A. A., Mullighan, C. G., Beverloo, H. B., van der Velden, V., Cornelissen, J. J., Valk, P. J. M., Rijneveld, A. W. & Sanders, M. A., Aug 2025, In: HemaSphere. 9, 8, e70195.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)29 Downloads (Pure) -
Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis
Boertjes, E. L., Massaar, S., Zeilemaker, A., Konijnenburg, J., Rijken, M., Kavelaars, F. G., Grob, T., Versluis, J., Löwenberg, B., Valk, P. J. M. & Sanders, M. A., 25 Mar 2025, In: Blood Advances. 9, 6, p. 1344-1355 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Citations (Web of Science)74 Downloads (Pure) -
Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML
Vonk, C. M., Grob, T., Rijken, M., Kavelaars, F. G., Konijnenburg, J., Ossenkoppele, G. J., Manz, M. G., Floisand, Y., Löwenberg, B. & Valk, P. J. M., 11 Mar 2025, In: Blood Advances. 9, 5, p. 1069-1077 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Citations (Scopus)78 Downloads (Pure)